EGFR and non-small cell lung carcinoma: Increasingly, molecular biomarkers are also being identified with prognostic significance in NSCLC, some with positive [e.g., EGFR (del-19 and L858R)] and others with negative (e.g., ERCC1, BRCA1, TP53, and KRAS) prognostic value (13).